Paul J. Tiseo
Chief Tech/Sci/R&D Officer at COGNITION THERAPEUTICS, INC.
Profile
Paul J.
Tiseo is currently the Vice President-Clinical Development at Cognition Therapeutics, Inc. Prior to this, he worked as the Executive Director-Clinical Development at Centrexion Therapeutics Corp.
He completed his undergraduate degree at Stony Brook University and his doctorate at Lewis Katz School of Medicine.
Paul J. Tiseo active positions
| Companies | Position | Start |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-10 |
Former positions of Paul J. Tiseo
| Companies | Position | End |
|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Training of Paul J. Tiseo
| Stony Brook University | Undergraduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Paul J. Tiseo
